Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: Toxicity, hormonal, and immunological effects

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1682-1689

  Propper, David J ^a   Saunders, Mark P ^a   Salisbury, Amanda J ^a   Long, Louise ^a   O'Byrne, Ken J ^a   Braybrooke, Jeremy P ^a   Dowsett, Mitchell ^a   Taylor, Marion ^a   Talbot, Denis C ^a   Ganesan, Trivadi S ^a   Harris, Adrian L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLOROADENOSINE 3',5' PHOSPHATE; HYDROXYPROGESTERONE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BONE MARROW TOXICITY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; HYPERCALCEMIA; KIDNEY CANCER; LUNG CANCER; LYMPHOCYTE ACTIVATION; MALE; MESOTHELIOMA; OVARY CANCER; PAROTID GLAND CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THYMOMA; TONGUE CANCER;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADULT; AGED; ANTINEOPLASTIC AGENTS; CYTOKINES; FEMALE; HORMONES; HUMANS; HYPERCALCEMIA; KIDNEY; LIVER; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; TREATMENT OUTCOME; VOMITING;

EID: 0032767068     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rodbell, M. The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature (Lond.), 284: 17-22, 1980.
2. Walsh, D. A., and Van, P. S. Multiple pathway signal transduction by the cAMP-dependent protein kinase. FASEB J., 8: 1227-1236, 1994.
3. Taylor, S. S., Buechler, J. A., and Yonemoto, W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem., 59: 971-1005, 1990.
4. Houge, G., Cho-Chung, Y. S., and Doskeland, S. O. Differential expression of cAMP-kinase subunits is correlated with growth in rat mammary carcinomas and uterus. Br. J. Cancer, 66: 1022-1029, 1992.
5. Tortora, G., Pepe, S., Yokozaki, H., Meissner, S., and Cho-Chung, Y. S. Cooperative effect of 8-Cl-cAMP and rhGM-CSF on the differentiation of HL-60 human leukemia cells. Biochem. Biophys. Res. Commun., 177: 1133-1140, 1991.
6. Tortora, G., Yokozaki, H., Pepe, S., Clair, T., and Cho-Chung, Y. S. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA, 88: 2011-2015, 1991.
7. Yokozaki, H., Budillon, A., Tortora, G., Meissner, S., Beaucage, S. L., Miki, K., and Cho-Chung, Y. S. An antisense oligodeoxynucleotide that depletes RI α subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res., 53: 868-872, 1993.
8. Nesterova, M., and Cho-Chung, Y. S. A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth. Nat. Med., 1: 528-533, 1995.
9. Cho-Chung, Y. S., Pepe, S., Clair, T., Budillon, A., and Nesterova, M. cAMP-dependent protein kinase: role in normal and malignant growth. Crit. Rev. Oncol. Hematol., 21: 1-3, 1995.
10. Ally, S., Clair, T., Katsaros, D., Tortora, G., Yokozaki, H., Finch, R. A., Avery, T. L., and Cho-Chung, Y. S. Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate. Cancer Res., 49: 5650-5655, 1989.
11. Ciardiello, F., Tortora, G., Kim, N., Clair, T., Ally, S., Salomon, D. S., and Cho-Chung, Y. S. 8-Chloro-cAMP inhibits transforming growth factor α transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. J. Biol. Chem., 265: 1016-1020, 1990.
12. Cho-Chung, Y. S., Clair, T., Tagliaferri, P., All, S., Katsaros, D., Tortora, G., Neckers, L., Avery, T., Crabtree, G. W., and Robins, R. K. Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest., 7: 161-177, 1989.
13. Scala, S., Budillon, A., Zhan, Z., Cho-Chung, Y. S., Jefferson, J., Tsokos, M., and Bates, S. E. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J. Clin. Invest., 96: 1026-1034, 1995.
14. Tagliaferri, P., Katsaros, D., Clair, T., Ally, S., Tortora, G., Neckers, L., Rubalcava, B., Parandoosh, Z., Chang, Y. A., Revankar, G. R., Crabtree, G. W., Robins, R. K., and Cho-Chung, Y. S. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res., 48: 1642-1650, 1988.
15. Tortora, G., Tagliaferri, P., Clair, T., Colamonici, O., Neckers, L. M., Robins, R. K., and Cho-Chung, Y. S. Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic human leukemia cell lines. Blood, 71: 230-233, 1988.
16. Pinto, A., Aldinucci, D., Gattei, V., Zagonel, V., Tortora, G., Budillon, A., and Cho-Chung, Y. S. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate. Proc. Natl. Acad. Sci. USA, 89: 8884-8888, 1992.
17. Cho-Chung, Y. S. Site-selective 8-chloro-cyclic adenosine 3′,5′-monophosphate as a biologic modulator of cancer: restoration of normal control mechanisms. J. Natl. Cancer Inst., 81: 982-987, 1989.
18. Rohlff, C., Safa, B., Rahman, A., Cho-Chung, Y. S., Klecker, R. W., and Glazer, R. I. Reversal of resistance to Adriamycin by 8-chloro-cyclic AMP in Adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities. Mol. Pharmacol., 43: 372-379, 1993.
19. Diisernia, G., Ciardiello, F., Sandomenico, C., Pepe, S., Bianco, A. R., and Tortora, G. 8-Chloro-cAMP enhances the growth-inhibitory effect of cytotoxic drugs in human colon-cancer cells. Int. J. Oncol., 9: 1233-1237, 1996.
20. Page, J. G., Rodman, L. E., Heath, J. E., Trang, J. M., and Rose, L. M. 30-Day Continuous Intravenous Infusion of 8-Chloroadenosine-3′,5′-Cyclic Monophosphate (NSC-614491) in Beagle Dogs, Publication No. NTIS/pb93. Springfield, VA: National Technical Information Service, 1993.
21. Tomaszewski, J. E., Sparks, R. M., Rose, L. M., Heath, J. E., and Page, J. G. Plasma drug levels and toxicity produced by intravenous infusions of 8-chloro-cyclic AMP (8-Cl-cAMP, NSC-614491) to beagle dogs. Proc. Am. Assoc. Cancer Res., 32: 425, 1991.
22. Spaulding, S. W. The ways in which hormones change cyclic adenosine 3′,5′-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocr. Rev., 14: 632-650, 1993.
23. McKnight, G. S., Clegg, C. H., Uhler, M. D., Chrivia, J. C., Cadd, G. G., Correll, L. A., and Otten, A. D. Analysis of the cAMP-dependent protein kinase system using molecular genetic approaches. Rec. Prog. Hormone Res., 44: 307-335, 1988.
24. Kammer, G. M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today, 9: 222-229, 1988.
25. Zhang, Y., Lin, J. X., and Vilcek, J. Synthesis of interleukin 6 (interferon-β2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J. Biol. Chem., 263: 6177-6182, 1988.
26. Bouma, M. G., Stad, R. K., Vandenwildenberg, F. A. J. M., and Buurman, W. A. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol., 153: 4159-4168, 1994.
27. Cummings, J., Leonard, R. C. F., and Miller, W. R. Sensitive determination of 8-chloroadenosine 3′,5′-monophosphate and 8-chloroadenosine in plasma by high-performance liquid-chromatography. J. Chromatogr. B Biomed. Appl., 658: 183-188, 1994.
28. Hudson, L., and Hay, F. C. Practical Immunology, pp. 118-126. Oxford: Blackwell Science Ltd., 1989.
29. Philip, P. A., Rea, D., Thavasu, P., Carmichael, J., Stuart, N., Rockett, H., Talbot, D. C., Ganesan, T., Pettit, G. R., Balkwill, F., and Harris, A. L. Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor α induction in vivo. J. Natl. Cancer Inst., 85: 1812-1818, 1993.
30. Saunders, M. P., Salisbury, A. J., O'Byrne, K. J., Long, L., Whitehouse, R. M., Talbot, D. C., Mawer, E. B., and Harris, A. L. A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors. J. Clin. Endocrinol. Metab., 82: 4044-4048, 1997.
31. Price, R. G. Measurement of N-acetyl-β-glucosaminidase and its isoenzymes in urine methods and clinical applications. Eur. J. Clin. Chem. Clin. Biochem., 30: 693-705, 1992.
32. Cummings, J., Langdon, S. P., Ritchie, A. A., Burns, D. J., MacKay, J., Stockman, P., Leonard, R. C. E., and Miller, W. R. Pharmacokinetics, metabolism and tumor disposition of 8-chloroadenosine 3′,5′-monophosphate in breast-cancer patients and xenograft bearing mice. Ann. Oncol., 7: 291-296, 1996.
33. Tortora, G., Ciardiello, F., Pepe, S., Tagliaferri, P., Ruggiero, A., Bianco, C., Guarrasi, R., and Miki, K. Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients. Clin. Cancer Res., 1: 377-384, 1995.
34. Langdon, S. P., Ritchie, A. A., Muir, M., Dodds, M., Howie, A. F., Leonard, R. C. F., Stockman, P. K., and Miller, W. R. Antitumour activity and schedule dependency of 8-chloroadenosine 3′,5′-monophosphate (8-Cl-cAMP) against human tumour xenografts. Eur. J. Cancer, 34: 384-388, 1998.
35. 3H]-8-cl-cAMP in mice by whole-body autoradiography of cryosections. Proc. Am. Assoc. Cancer Res., 31: 382, 1990.
36. Garrel, G., McArdle, C. A., Hemmings, B. A., and Counis, R. Gonadotrophin-releasing hormone and pituitary adenylate cyclase-activating polypeptide affect levels of cyclic adenosine 3′,5′-monophosphate-dependent protein kinase A (PKA) subunits in the clonal gonadotrope α T3 cell: evidence for cross-talk between PKA and protein kinase C pathways. Endocrinology, 138: 2259-2256, 1997.
37. Evans, S. W., Beckner, S. K., and Farrar, W. L. Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by interleukin-2 [published erratum in Nature (Lond.), 327: 467, 1987]. Nature (Lond.), 325: 166-168, 1987.
38. Laxminarayana, D., Berrada, A., and Kammer, G. M. Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J. Clin. Invest., 92: 2207-2214, 1993.